Insulin-like peptide 5 is a microbially regulated peptide that promotes hepatic glucose production

Molecular Metabolism

Volumn 5, Issue 4, 2016, Pages 263-270

  Lee, Ying Shiuan ^a   De Vadder, Filipe ^a,b,c,d   Tremaroli, Valentina ^a   Wichmann, Anita ^a,f   Mithieux, Gilles ^b,c,d   Bäckhed, Fredrik ^a,e  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE   (France)

^c UNIVERSITÉ DE LYON   (France)

^d UNIVERSITÉ LYON 1   (France)

^e Capital Region   (Denmark)

^f CHR HANSEN A S   (Denmark)

Author keywords

Colon; Gut microbiota; Insulin like peptide 5 (INSL5); Liver

Indexed keywords

INSULIN LIKE PEPTIDE 5; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN STEM; CONTROLLED STUDY; FAT CONTENT; GLUCONEOGENESIS; HYPOTHALAMUS; INTESTINE FLORA; LIVER METABOLISM; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION;

EID: 84957921872     PISSN: None     EISSN: 22128778     Source Type: Journal    
DOI: 10.1016/j.molmet.2016.01.007     Document Type: Article

References (45)

1. Conklin D., Lofton-Day C.E., Haldeman B.A., Ching A., Whitmore T.E., Lok S., et al. Identification of INSL5, a new member of the insulin superfamily. Genomics 1999, 60:50-56.
2. Bell G.I., Pictet R.L., Rutter W.J., Cordell B., Tischer E., Goodman H.M. Sequence of the human insulin gene. Nature 1980, 284:26-32.
3. Rinderknecht E., Humbel R.E. The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin. Journal of Biological Chemistry 1978, 253:2769-2776.
4. Bell G.I., Merryweather J.P., Sanchez-Pescador R., Stempien M.M., Priestley L., Scott J., et al. Sequence of a cDNA clone encoding human preproinsulin-like growth factor II. Nature 1984, 310:775-777.
5. Bathgate R.A., Halls M.L., van der Westhuizen E.T., Callander G.E., Kocan M., Summers R.J. Relaxin family peptides and their receptors. Physiological Reviews 2013, 93:405-480.
6. Liu C., Kuei C., Sutton S., Chen J., Bonaventure P., Wu J., et al. INSL5 is a high affinity specific agonist for GPCR142 (GPR100). Journal of Biological Chemistry 2005, 280:292-300.
7. Mashima H., Ohno H., Yamada Y., Sakai T., Ohnishi H. INSL5 may be a unique marker of colorectal endocrine cells and neuroendocrine tumors. Biochemical and Biophysical Research Communications 2013, 432:586-592.
8. Thanasupawat T., Hammje K., Adham I., Ghia J.E., Del Bigio M.R., Krcek J., et al. INSL5 is a novel marker for human enteroendocrine cells of the large intestine and neuroendocrine tumours. Oncology Reports 2013, 29:149-154.
9. Tager H., Given B., Baldwin D., Mako M., Markese J., Rubenstein A., et al. A structurally abnormal insulin causing human diabetes. Nature 1979, 281:122-125.
10. Powell-Braxton L., Hollingshead P., Warburton C., Dowd M., Pitts-Meek S., Dalton D., et al. IGF-I is required for normal embryonic growth in mice. Genes & Development 1993, 7:2609-2617.
11. Liu J.P., Baker J., Perkins A.S., Robertson E.J., Efstratiadis A. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 1993, 75:59-72.
12. Anand-Ivell R., Ivell R. Regulation of the reproductive cycle and early pregnancy by relaxin family peptides. Molecular and Cellular Endocrinology 2014, 382:472-479.
13. Burnicka-Turek O., Mohamed B.A., Shirneshan K., Thanasupawat T., Hombach-Klonisch S., Klonisch T., et al. INSL5-deficient mice display an alteration in glucose homeostasis and an impaired fertility. Endocrinology 2012, 153:4655-4665.
14. Luo X., Li T., Zhu Y., Dai Y., Zhao J., Guo Z.Y., et al. The insulinotrophic effect of insulin-like peptide 5 in vitro and in vivo. Biochemical Journal 2015, 466:467-473.
15. Grosse J., Heffron H., Burling K., Akhter Hossain M., Habib A.M., Rogers G.J., et al. Insulin-like peptide 5 is an orexigenic gastrointestinal hormone. Proceedings of the National Academy of Sciences of the United States of America 2014, 111:11133-11138.
16. Hoverstad T., Midtvedt T. Short-chain fatty acids in germfree mice and rats. Journal of Nutrition 1986, 116:1772-1776.
17. Wostmann B.S., Larkin C., Moriarty A., Bruckner-Kardoss E. Dietary intake, energy metabolism, and excretory losses of adult male germfree Wistar rats. Laboratory Animal Science 1983, 33:46-50.
18. Gill S.R., Pop M., Deboy R.T., Eckburg P.B., Turnbaugh P.J., Samuel B.S., et al. Metagenomic analysis of the human distal gut microbiome. Science 2006, 312:1355-1359.
19. Backhed F., Ding H., Wang T., Hooper L.V., Koh G.Y., Nagy A., et al. The gut microbiota as an environmental factor that regulates fat storage. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:15718-15723.
20. Donohoe D.R., Garge N., Zhang X., Sun W., O'Connell T.M., Bunger M.K., et al. The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon. Cell Metabolism 2011, 13:517-526.
21. Wichmann A., Allahyar A., Greiner T.U., Plovier H., Lunden G.O., Larsson T., et al. Microbial modulation of energy availability in the colon regulates intestinal transit. Cell Host & Microbe 2013, 14:582-590.
22. Larsson E., Tremaroli V., Lee Y.S., Koren O., Nookaew I., Fricker A., et al. Analysis of gut microbial regulation of host gene expression along the length of the gut and regulation of gut microbial ecology through MyD88. Gut 2012, 61:1124-1131.
23. Baginsky E., Foa P., Zak B. Methods of enzymatic analysis. Methods of enzymatic analysis 1974, 876-880. NYUCH Publishers, New York. H.U. Bergmeyer (Ed.).
24. Keppler D., Decker K. Methods of enzymatic analysis. Methods of enzymatic analysis 1981, 11-18. Verlag Chemie, Weinhem, Germany. H.U. Bergmeyer (Ed.).
25. Xu J., Bjursell M.K., Himrod J., Deng S., Carmichael L.K., Chiang H.C., et al. A genomic view of the human-Bacteroides thetaiotaomicron symbiosis. Science 2003, 299:2074-2076.
26. Holst J.J. The physiology of glucagon-like peptide 1. Physiological Reviews 2007, 87:1409-1439.
27. Batterham R.L., Bloom S.R. The gut hormone peptide YY regulates appetite. Annals of the New York Academy of Sciences 2003, 994:162-168.
28. Wahren J., Ekberg K. Splanchnic regulation of glucose production. Annual Review of Nutrition 2007, 27:329-345.
29. Rognstad R., Katz J. Gluconeogenesis in the kidney cortex. Quantitative estimation of carbon flow. Journal of Biological Chemistry 1972, 247:6047-6054.
30. Stumvoll M., Meyer C., Mitrakou A., Nadkarni V., Gerich J.E. Renal glucose production and utilization: new aspects in humans. Diabetologia 1997, 40:749-757.
31. Postic C., Dentin R., Girard J. Role of the liver in the control of carbohydrate and lipid homeostasis. Diabetes & Metabolism 2004, 30:398-408.
32. Scrocchi L.A., Brown T.J., MaClusky N., Brubaker P.L., Auerbach A.B., Joyner A.L., et al. Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene. Nature Medicine 1996, 2:1254-1258.
33. Niijima A. Afferent impulse discharges from glucoreceptors in the liver of the guinea pig. Annals of the New York Academy of Sciences 1969, 157:690-700.
34. Hevener A.L., Bergman R.N., Donovan C.M. Portal vein afferents are critical for the sympathoadrenal response to hypoglycemia. Diabetes 2000, 49:8-12.
35. Hevener A.L., Bergman R.N., Donovan C.M. Novel glucosensor for hypoglycemic detection localized to the portal vein. Diabetes 1997, 46:1521-1525.
36. Stumpel F., Jungermann K. Sensing by intrahepatic muscarinic nerves of a portal-arterial glucose concentration gradient as a signal for insulin-dependent glucose uptake in the perfused rat liver. FEBS Letters 1997, 406:119-122.
37. Stumpel F., Scholtka B., Jungermann K. Impaired glucose sensing by intrahepatic, muscarinic nerves for an insulin-stimulated hepatic glucose uptake in streptozotocin-diabetic rats. FEBS Letters 1998, 436:185-188.
38. Myers S.R., Biggers D.W., Neal D.W., Cherrington A.D. Intraportal glucose delivery enhances the effects of hepatic glucose load on net hepatic glucose uptake in vivo. Journal of Clinical Investigation 1991, 88:158-167.
39. Moore M.C., Shulman G.I., Giaccari A., Pagliassotti M.J., Cline G., Neal D., et al. Effect of hepatic nerves on disposition of an intraduodenal glucose load. American Journal of Physiology 1993, 265:E487-E496.
40. Moore M.C., Satake S., Baranowski B., Hsieh P.S., Neal D.W., Cherrington A.D. Effect of hepatic denervation on peripheral insulin sensitivity in conscious dogs. American Journal of Physiology, Endocrinology and Metabolism 2002, 282:E286-E296.
41. Smith E.P., An Z., Wagner C., Lewis A.G., Cohen E.B., Li B., et al. The role of beta cell glucagon-like peptide-1 signaling in glucose regulation and response to diabetes drugs. Cell Metabolism 2014, 19:1050-1057.
42. Wagle S.R., Ingebretsen W.R. Stimulation of glycogenolysis by epinephrine and glucagon and its inhibition by insulin in isolated rat liver hepatocytes. Biochemical and Biophysical Research Communications 1973, 52:125-129.
43. Exton J.H., Park C.R. Control of gluconeogenesis in liver. II. Effects of glucagon, catecholamines, and adenosine 3',5'-monophosphate on gluconeogenesis in the perfused rat liver. Journal of Biological Chemistry 1968, 243:4189-4196.
44. Ayala J.E., Samuel V.T., Morton G.J., Obici S., Croniger C.M., Shulman G.I., et al. Standard operating procedures for describing and performing metabolic tests of glucose homeostasis in mice. Disease Models & Mechanisms 2010, 3:525-534.
45. McGuinness O.P., Ayala J.E., Laughlin M.R., Wasserman D.H. NIH experiment in centralized mouse phenotyping: the Vanderbilt experience and recommendations for evaluating glucose homeostasis in the mouse. American Journal of Physiology, Endocrinology and Metabolism 2009, 297:E849-E855.